Used in pharmaceutical research as a potent inhibitor of soluble epoxide hydrolase (sEH), this compound plays a role in reducing inflammation and pain by stabilizing endogenous epoxy fatty acids. It has shown potential in preclinical studies for treating neuropathic pain, inflammatory conditions, and certain cardiovascular diseases. Its structure allows for high selectivity and improved metabolic stability, making it a valuable scaffold in developing new anti-inflammatory agents.